• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮腔内肾血管成形术对肾动脉狭窄性高血压患者自主神经系统和利钠作用的影响。

Impact of Percutaneous Transluminal Renal Angioplasty on Autonomic Nervous System and Natriuresis in Hypertensive Patients With Renal Artery Stenosis.

机构信息

Department of Nephrology and Hypertension Dokkyo Medical University Tochigi Japan.

Division of Hypertension and Nephrology National Cerebral and Cardiovascular Center Osaka Japan.

出版信息

J Am Heart Assoc. 2022 Mar 15;11(6):e023655. doi: 10.1161/JAHA.121.023655. Epub 2022 Mar 9.

DOI:10.1161/JAHA.121.023655
PMID:35261276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9075284/
Abstract

Background We investigated the early postoperative effect of percutaneous transluminal renal angioplasty on ambulatory blood pressure (BP) and the circadian characteristics of natriuresis and autonomic nerve activity. Methods and Results A total of 64 patients with hypertension with hemodynamically significant renal artery stenosis (mean age, 60.0±21.0 years; 31.3% fibromuscular dysplasia) who underwent angioplasty were included, and circadian characteristics of natriuresis as well as heart rate variability indices, including 24-hour BP, low-frequency and high-frequency (HF) components, and the percentage of differences between adjacent normal R-R intervals >50 ms were evaluated using an oscillometric device, TM-2425, both at baseline and 3 days after angioplasty. In both the fibromuscular dysplasia and atherosclerotic stenosis groups, 24-hour systolic BP (fibromuscular dysplasia, -19±14; atherosclerotic renal artery stenosis, -11±9 mm Hg), percentage of differences between adjacent normal R-R intervals >50 ms, HF, brain natriuretic peptide, and nighttime urinary sodium excretion decreased (all <0.01), and heart rate increased (both <0.05) after angioplasty. In both groups, revascularization increased the night/day ratios of percentage of differences between adjacent normal R-R intervals >50 ms (both <0.01) and HF, and decreased those of low frequency/HF (all <0.05) and nighttime urinary sodium excretion (fibromuscular dysplasia, 1.17±0.15 to 0.78±0.09; atherosclerotic renal artery stenosis, 1.37±0.10 to 0.99±0.06, both <0.01). Multiple logistic regression analysis indicated that a 1-SD increase in baseline low frequency/HF was associated with at least a 15% decrease in 24-hour systolic BP after angioplasty (odds ratio, 2.30 [95% CI, 1.03-5.67]; <0.05). Conclusions Successful revascularization results in a significant BP decrease in the early postoperative period. Intrarenal perfusion might be a key modulator of the circadian patterns of autonomic nerve activity and natriuresis, and pretreatment heart rate variability evaluation seems to be important for treatment success.

摘要

背景

我们研究了经皮腔内肾血管成形术对动态血压(BP)和利钠及自主神经活动昼夜节律特征的早期术后影响。

方法和结果

共纳入 64 例患有高血压且伴血流动力学显著肾动脉狭窄的患者(平均年龄 60.0±21.0 岁;31.3%为纤维肌性发育不良),使用示波法装置 TM-2425 在基线和血管成形术后 3 天评估利钠的昼夜节律特征以及心率变异性指数,包括 24 小时 BP、低频和高频(HF)成分以及相邻正常 R-R 间期差值>50 ms 的百分比。在纤维肌性发育不良和动脉粥样硬化性狭窄组中,24 小时收缩压(纤维肌性发育不良,-19±14;动脉粥样硬化性肾动脉狭窄,-11±9 mmHg)、相邻正常 R-R 间期差值>50 ms 的百分比、HF、脑利钠肽和夜间尿钠排泄均降低(均<0.01),心率增加(均<0.05)。两组血管再通后,相邻正常 R-R 间期差值>50 ms 的夜间/日间比值(均<0.01)和 HF 增加,低频/HF 比值(均<0.05)和夜间尿钠排泄减少(纤维肌性发育不良,1.17±0.15 至 0.78±0.09;动脉粥样硬化性肾动脉狭窄,1.37±0.10 至 0.99±0.06,均<0.01)。多变量逻辑回归分析表明,基线时低频/HF 每增加 1 个标准差,血管成形术后 24 小时收缩压至少降低 15%(比值比,2.30[95%可信区间,1.03-5.67];<0.05)。

结论

成功的血管再通可导致术后早期血压显著下降。肾内灌注可能是自主神经活动和利钠昼夜节律模式的关键调节因子,治疗前心率变异性评估对治疗成功似乎很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/ba6cd3403541/JAH3-11-e023655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/f88d14988e33/JAH3-11-e023655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/b02a8ae7472a/JAH3-11-e023655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/ba6cd3403541/JAH3-11-e023655-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/f88d14988e33/JAH3-11-e023655-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/b02a8ae7472a/JAH3-11-e023655-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aa8/9075284/ba6cd3403541/JAH3-11-e023655-g003.jpg

相似文献

1
Impact of Percutaneous Transluminal Renal Angioplasty on Autonomic Nervous System and Natriuresis in Hypertensive Patients With Renal Artery Stenosis.经皮腔内肾血管成形术对肾动脉狭窄性高血压患者自主神经系统和利钠作用的影响。
J Am Heart Assoc. 2022 Mar 15;11(6):e023655. doi: 10.1161/JAHA.121.023655. Epub 2022 Mar 9.
2
Effects of Percutaneous Transluminal Renal Angioplasty on Office and Home Blood Pressure and Home Blood Pressure Variability in Hypertensive Patients With Renal Artery Stenosis.经皮腔内肾血管成形术对肾动脉狭窄高血压患者诊室血压、家庭血压及家庭血压变异性的影响。
Hypertension. 2017 Jan;69(1):109-117. doi: 10.1161/HYPERTENSIONAHA.116.08124. Epub 2016 Nov 21.
3
Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.经皮腔内血管成形术/支架置入治疗肾血管平滑肌脂肪瘤:十年随访结果
J Vasc Surg. 2012 Feb;55(2):421-7. doi: 10.1016/j.jvs.2011.09.006. Epub 2011 Nov 23.
4
Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study.纤维肌性发育不良患者肾动脉血运重建的血管内压力测量的见解:DYSART 研究。
J Vasc Surg. 2022 Mar;75(3):939-949.e1. doi: 10.1016/j.jvs.2021.09.023. Epub 2021 Sep 30.
5
Treatment of renovascular hypertension with percutaneous transluminal angioplasty: experience in Spain.经皮腔内血管成形术治疗肾血管性高血压:西班牙的经验。
J Vasc Interv Radiol. 1994 Jan-Feb;5(1):101-9. doi: 10.1016/s1051-0443(94)71462-7.
6
Impact of Percutaneous Revascularization on Left Ventricular Mass and Its Relationship to Outcome in Hypertensive Patients With Renal Artery Stenosis.经皮血管重建术对高血压合并肾动脉狭窄患者左心室质量的影响及其与预后的关系。
Am J Hypertens. 2020 May 21;33(6):570-580. doi: 10.1093/ajh/hpaa036.
7
Cure and improvement of renovascular hypertension after percutaneous transluminal angioplasty of renal artery stenosis.经皮腔内肾动脉血管成形术后肾血管性高血压的治愈与改善
Nephron. 1989;51(3):362-6. doi: 10.1159/000185323.
8
Surgical treatment of renal artery stenosis after failed percutaneous transluminal angioplasty.经皮腔内血管成形术失败后肾动脉狭窄的外科治疗。
J Urol. 1990 Nov;144(5):1094-6. doi: 10.1016/s0022-5347(17)39666-0.
9
Long-term experience in percutaneous transluminal dilatation of renal artery stenosis.经皮肾动脉狭窄腔内扩张术的长期经验。
Am J Med. 1985 Dec;79(6):692-8. doi: 10.1016/0002-9343(85)90519-4.
10
Focal renal artery stenosis caused by fibromuscular dysplasia: treatment by percutaneous transluminal angioplasty.纤维肌性发育异常所致局灶性肾动脉狭窄:经皮腔内血管成形术治疗
AJR Am J Roentgenol. 1988 Sep;151(3):593-6. doi: 10.2214/ajr.151.3.593.

引用本文的文献

1
Atherosclerotic renal artery stenosis, mediating biomarkers, and risk of cardiac among individuals with hypertension: A real-world study.高血压患者中动脉粥样硬化性肾动脉狭窄、介导生物标志物与心脏风险:一项真实世界研究
Int J Cardiol Heart Vasc. 2024 Nov 18;55:101556. doi: 10.1016/j.ijcha.2024.101556. eCollection 2024 Dec.

本文引用的文献

1
Resistant Hypertension and Atherosclerotic Renal Artery Stenosis: Effects of Angioplasty on Ambulatory Blood Pressure. A Retrospective Uncontrolled Single-Center Study.抗高血压与动脉粥样硬化性肾动脉狭窄:经皮腔内血管成形术对动态血压的影响。一项回顾性非对照单中心研究。
Hypertension. 2019 Dec;74(6):1516-1523. doi: 10.1161/HYPERTENSIONAHA.119.13393. Epub 2019 Oct 28.
2
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Hypertension. 2018 Jun;71(6):e13-e115. doi: 10.1161/HYP.0000000000000065. Epub 2017 Nov 13.
3
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
4
SCAI appropriate use criteria for peripheral arterial interventions: An update.SCAI外周动脉介入治疗的合理使用标准:更新版
Catheter Cardiovasc Interv. 2017 Oct 1;90(4):E90-E110. doi: 10.1002/ccd.27141. Epub 2017 Jun 5.
5
B-type natriuretic peptide-guided treatment for heart failure.B型利钠肽指导下的心力衰竭治疗
Cochrane Database Syst Rev. 2016 Dec;12(12):CD008966. doi: 10.1002/14651858.CD008966.pub2. Epub 2016 Dec 22.
6
Effects of Percutaneous Transluminal Renal Angioplasty on Office and Home Blood Pressure and Home Blood Pressure Variability in Hypertensive Patients With Renal Artery Stenosis.经皮腔内肾血管成形术对肾动脉狭窄高血压患者诊室血压、家庭血压及家庭血压变异性的影响。
Hypertension. 2017 Jan;69(1):109-117. doi: 10.1161/HYPERTENSIONAHA.116.08124. Epub 2016 Nov 21.
7
Comparative Effectiveness of Management Strategies for Renal Artery Stenosis: An Updated Systematic Review.肾动脉狭窄管理策略的比较效果:一项更新的系统评价。
Ann Intern Med. 2016 Nov 1;165(9):635-649. doi: 10.7326/M16-1053. Epub 2016 Aug 16.
8
Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.肾动脉狭窄高血压患者经皮腔内肾血管成形术后再狭窄的发生率、危险因素及其对血压控制的影响。
J Hypertens. 2016 Jul;34(7):1407-15. doi: 10.1097/HJH.0000000000000928.
9
The autonomic nervous system and hypertension.自主神经系统与高血压。
Circ Res. 2014 May 23;114(11):1804-14. doi: 10.1161/CIRCRESAHA.114.302524.
10
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.纤维肌性发育异常:科学现状与关键未解决问题:美国心脏协会的科学声明
Circulation. 2014 Mar 4;129(9):1048-78. doi: 10.1161/01.cir.0000442577.96802.8c. Epub 2014 Feb 18.